[ER stress and NAFLD].

Q4 Biochemistry, Genetics and Molecular Biology
Biologie Aujourd''hui Pub Date : 2020-01-01 Epub Date: 2020-08-10 DOI:10.1051/jbio/2020007
Floriane Lachkar, Alexandra Papaioannou, Pascal Ferré, Fabienne Foufelle
{"title":"[ER stress and NAFLD].","authors":"Floriane Lachkar,&nbsp;Alexandra Papaioannou,&nbsp;Pascal Ferré,&nbsp;Fabienne Foufelle","doi":"10.1051/jbio/2020007","DOIUrl":null,"url":null,"abstract":"<p><p>Non-alcoholic fatty liver disease (NAFLD) is a highly prevalent pathology associated with obesity. It encompasses a spectrum of hepatic disorders ranging from steatosis to non-alcoholic steatohepatitis (NASH), which may lead to cirrhosis and hepatocellular carcinoma (HCC). Endoplasmic reticulum (ER) stress has been widely involved to drive in NAFLD progression through the activation of the unfolded protein response (UPR). While transient UPR activation can boost hepatic ER functions, its continuous activation upon a chronic ER stress contributes to lipid accumulation, inflammation and hepatocyte death, which are determinant factors for the progression to more severe stages. The aim of this review is to describe the mechanisms through which the UPR can take part in the transition from a healthy to a diseased liver and to report on possible ways of pharmacological manipulation against these pathological mechanisms.</p>","PeriodicalId":39068,"journal":{"name":"Biologie Aujourd''hui","volume":"214 1-2","pages":"15-23"},"PeriodicalIF":0.0000,"publicationDate":"2020-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1051/jbio/2020007","citationCount":"7","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Biologie Aujourd''hui","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1051/jbio/2020007","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2020/8/10 0:00:00","PubModel":"Epub","JCR":"Q4","JCRName":"Biochemistry, Genetics and Molecular Biology","Score":null,"Total":0}
引用次数: 7

Abstract

Non-alcoholic fatty liver disease (NAFLD) is a highly prevalent pathology associated with obesity. It encompasses a spectrum of hepatic disorders ranging from steatosis to non-alcoholic steatohepatitis (NASH), which may lead to cirrhosis and hepatocellular carcinoma (HCC). Endoplasmic reticulum (ER) stress has been widely involved to drive in NAFLD progression through the activation of the unfolded protein response (UPR). While transient UPR activation can boost hepatic ER functions, its continuous activation upon a chronic ER stress contributes to lipid accumulation, inflammation and hepatocyte death, which are determinant factors for the progression to more severe stages. The aim of this review is to describe the mechanisms through which the UPR can take part in the transition from a healthy to a diseased liver and to report on possible ways of pharmacological manipulation against these pathological mechanisms.

[ER压力和NAFLD]。
非酒精性脂肪性肝病(NAFLD)是一种与肥胖相关的非常普遍的病理。它包括一系列肝脏疾病,从脂肪变性到可能导致肝硬化和肝细胞癌(HCC)的非酒精性脂肪性肝炎(NASH)。内质网(ER)应激通过激活未折叠蛋白反应(UPR)被广泛参与驱动NAFLD的进展。虽然短暂的UPR激活可以促进肝脏内质网功能,但其在慢性内质网应激下的持续激活会导致脂质积累、炎症和肝细胞死亡,这些都是进展到更严重阶段的决定性因素。本综述的目的是描述普遍定期审议参与从健康肝脏到病变肝脏转变的机制,并报告针对这些病理机制的可能药理学操作方法。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Biologie Aujourd''hui
Biologie Aujourd''hui Biochemistry, Genetics and Molecular Biology-Biochemistry, Genetics and Molecular Biology (all)
CiteScore
0.30
自引率
0.00%
发文量
9
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信